Evaluation Of The Degree Of Integration Between The Innovation Chain And The Capital Chain In Biomedical Enterprises

Biological pharmaceutical enterprise innovation in the 21 st century is active and far-reaching emerging industries,is one of the important direction of development of strategic emerging industry in China,biological pharmaceutical enterprise innovation and development for our country in the future science and technology revolution and industrial progress on secure key position,and promote the development of health industry,looking for a new economic growth point has important significance.Relevant polic ies and regulations of the state to promote the innovative development of biological pharmaceutical companies,biomedical companies increase investment in research and development,Wind data show that in the first half of 2019 A shares comparable data of 2 98 biomedical companies R&D spending A total of 20.35 billion yuan,up 17.89% from a year earlier,the average R&D enterprises reached 70 million yuan,but the innovation growth of biological pharmaceutical enterprises in China is relatively slow compared with the developed country,therefore how to combine financial support and enterprise innovation effectively,make innovation chain and capital chain depth integration,thus promotes the innovation and development of biological medicine enterprise,It has become an urgent problem to be solved by biomedical enterprises.Based on the characteristics of biomedical enterprises,this paper studies the integration of the innovation chain and capital chain of biomedical enterprise s investigate object,based on the analysis of biological medicine enterprise innovation chain and capital chain,on the basis of the structure and characteristics of the biological medicine enterprise innovation chain and capital chain integration concept definition,analysis of biologica l medicine enterprise innovation chain and the role of the capital chain relationship,based on the influence factors of innovation chain and capital chain integration analysis,from the conditions of the fusion and integration ability and the effect of th e fusion of three dimensions,construction of biological medicine enterprise innovation chain and capital chain alignment evaluation index system,using the extension matter-element model of biological pharmaceutical enterprise innovation chain and capital chain alignment evaluation,comprehensive evaluation results and influencing factors analysis,The strategy of promoting the integration of innovation chain and capital chain in biomedical enterprises is put forward.The research of this paper can provide a method and reference for the evaluation of the integration degree of the innovation chain and capital chain of biomedical enterprises,and it is of great significance for the improvement of the integration development of the innovation chain and capital chain of biomedical enterprises.